NCT02410083View on ClinicalTrials.gov

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

PHASE4CompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

December 31, 2015

Conditions
ANEURYSM CORONARY ARTERY
Interventions
DRUG

Clopirin 1

DRUG

Clopidogrel-Aspirin(co-administration) 1

DRUG

Clopirin 2

DRUG

Clopidogrel-Aspirin(co-administration) 2

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT02410083 - Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent | Biotech Hunter | Biotech Hunter